by NIH Newsbot
HIV-infected adults currently are being recruited to participate in a clinical trial of 2009 H1N1 influenza vaccine. The study, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health, will enroll approximately 240 men and women between the ages of 18 and 64.
Posted on Thursday, December 10, 2009
Topic: Cold & Flu, NIH Research News
(No Ratings Yet)
Print Post
Like this article? Highlight HEALTH delivers weekly articles on the science of health. Join the community by subscribing (more).
Height: articles per wek
Opacity: # of comments
(5.00 out of 5) (5.00 out of 5) (5.00 out of 5) (5.00 out of 5) (5.00 out of 5) (5.00 out of 5)
Interesting links from the
Highlight HEALTH Web Directory
No responses to "NIAID Trial of 2009 H1N1 Influenza Vaccine Enrolling HIV-Positive Adults"
Comments on this story? Leave a note below.
Comments are closed.